Genetic Testing Oversight Public Input Sought By HHS Advisory Panel
This article was originally published in The Gray Sheet
Executive Summary
HHS' Advisory Committee on Genetic Testing will solicit public input at a Jan. 27 meeting to help determine an appropriate mechanism for the collection and analysis of data on the analytical validity, clinical validity and clinical utility of genetics tests, panel members agreed at their Oct. 26 meeting.
You may also be interested in...
CDC To Lead Data Accrual On Clinical Validity Of Genetic Tests
The Centers for Disease Control and Prevention will establish a public/private consortium to recommend clinical validation and post-marketing data collection processes for predictive genetic disease tests.
CDC To Lead Data Accrual On Clinical Validity Of Genetic Tests
The Centers for Disease Control and Prevention will establish a public/private consortium to recommend clinical validation and post-marketing data collection processes for predictive genetic disease tests.
HHS Genetic Testing Advisory Committee To Include Device, CLIA Panel Reps
HHS' planned Advisory Committee on Genetic Testing will include at least one active member of FDA's Medical Devices Advisory Committee and the Clinical Laboratory Improvement Advisory Committee, according to the group's charter.